Ładuje się......
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day...
Zapisane w:
| Wydane w: | J Formos Med Assoc |
|---|---|
| Główni autorzy: | , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Formosan Medical Association. Published by Elsevier Taiwan LLC.
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8059939/ https://ncbi.nlm.nih.gov/pubmed/33933336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jfma.2021.04.010 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|